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Abstract
Aim The aim of this study is to evaluate racial variation
in umbilical cord blood concentration of vitamin D and to
explore its correlation with markers of the insulin-like
growth factor axis (IGFs) and sex steroid hormones in
white and black male neonates.
Methods In 2004–2005, venous umbilical cord blood
samples were collected from 75 black and 38 white male
neonates, along with maternal and birth characteristics
from two hospitals in Maryland, United States. 25-Hy-
droxyvitamin D [25(OH)D] and 1,25-dihydroxyvitamin
D [1,25(OH)2D] were measured by radioimmunoassay and
testosterone, estradiol, and sex hormone-binding globulin
(SHBG) by immunoassay and IGF-1, IGF-2, and IGF-
binding protein-3 by ELISA. Crude and multivariable-
adjusted geometric mean concentrations were computed.
Results Mean 25(OH)D levels were lower in black than
in white neonates (11.44; 95 % CI 10.10–12.95 ng/mL vs.
18.24; 95 % CI 15.32–21.72 ng/mL; p \ 0.0001). Black
neonates were at higher risk of suboptimal vitamin D levels
[25(OH)D \ 20 ng/mL] than whites (84 vs. 63 %).
25(OH)D concentrations varied by season in whites but not
in blacks and were significantly inversely correlated with
mother’s parity (number of live births) in blacks but not in
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whites. Mean concentration of 1,25(OH)2D did not differ
by race. 25(OH)D and 1,25(OH)2D did not correlate with
IGFs, sex steroid hormones, and SHBG.
Conclusions Suboptimal vitamin D levels were prevalent
especially in blacks and influenced by mother’s parity and
by season. The observed vitamin D differences between
black and white neonates warrant further evaluation of the
etiology of the disparity in chronic diseases in adulthood.
Keywords Vitamin D  Umbilical cord blood 
Black and white Americans
Introduction
Significant differences exist between black and white Amer-
icans in relation to the risk of chronic diseases such as car-
diovascular disease and cancer [1–4]. Variations in the
prevalence of exposure to factors thought to play a role in the
etiology of these diseases may contribute to the observed
health disparities. Vitamin D is a candidate to be studied.
Suboptimal vitamin D level is thought to be associated with a
range of diseases such as diabetes, cardiovascular disease, and
several types of cancer [5]. Due to their greater skin pig-
mentation, blacks have lower endogenous formation of vita-
min D and, thus, often lower circulating levels than white
individuals living at the same latitude [6].
It is thought that some chronic diseases have their ori-
gins in early life and even in utero, such that Barker et al.
[7] suggested that fetuses react and adapt to their nutrient
supply during prenatal growth with consequences for the
risk of chronic diseases later in life. It is therefore plausible
that vitamin D deficiency in utero or early childhood also
affects the risk of these diseases [8].
The main circulating form of vitamin D is 25-hydrox-
yvitamin D [25(OH)D], which is metabolized into 1,25-
dihydroxyvitamin D [1,25(OH)2D], the biologically active
form of vitamin D. 1,25(OH)2D enters cells by passive
diffusion and binds to the vitamin D receptor of the
nucleus, which ultimately leads to changes in gene tran-
scription [9]. In the fetus, 1,25(OH)2D has several func-
tions; it is, for example, involved in glucose metabolism
[10], which fits into Barker’s hypothesis [10, 11].
During the last century, vitamin D fortification programs
have largely eradicated the health risks of vitamin D defi-
ciency such as rickets and osteomalacia from Western popu-
lations. However, the risk of vitamin D deficiency is again
prevalent in industrialized nations [12–14]. So far, few studies
examined vitamin D concentrations in black and white
American mothers and their neonates, for example [12, 15–17].
Specifically, a Pittsburgh study reported higher concentra-
tions of 25(OH)D in white than in black women and their
neonates [16]. 25(OH)D is considered indicative of an
individual’s vitamin D status, whereas 1,25(OH)2D is ho-
meostatically controlled in the blood [18]. Few studies have
examined racial differences in 1,25(OH)2D concentrations
in cord blood of full-term births [15]. Insulin-like growth
factor-1 (IGF-1) stimulates renal and placental 1,25(OH)2D
production [19], but the association between these two
markers has rarely been investigated in cord or maternal
blood [20]. Even less is known about the relationship
between vitamin D and sex steroid hormones during fetal
development. So far, one in vitro study has shown that
vitamin D is a physiological regulator of placental estradiol
and progesterone secretion [21]. To the best of our knowl-
edge, no one has yet examined racial variation in the corre-
lation between vitamin D and these other hormones.
In the present study, we examined whether venous umbilical
cord blood concentrations of 25-hydroxyvitamin D [25(OH)D]
and 1,25-dihydroxyvitamin D [1,25(OH)2D] differed between
75 black and 38 white American male neonates. In addition, the
correlation of insulin-like growth factor-1 (IGF-I), sex steroid
hormones, and sex hormone-binding globulin (SHBG) with
cord blood vitamin D levels was assessed by race.
Methods
Study population
The current study, called the Hormones in Umbilical Cord
Blood Study (HUB Study), was conducted as a pilot project
as part of the partnership between the Howard University
Cancer Center and the Sidney Kimmel Comprehensive
Cancer Center at Johns Hopkins, which was funded by the
National Cancer Institute (U54 CA091409 and CA091431).
The Institutional Review Boards of Prince George’s Hos-
pital Center and the Johns Hopkins Bloomberg School of
Public Health approved the joint study.
Umbilical cord blood samples were collected from neonates
born at Prince George’s Hospital Center in Cheverly, MD
(hospital 1), and Johns Hopkins Hospital in Baltimore, MD
(hospital 2), between February 2004 and June 2005. The
delivery room nurses collected venous umbilical cord samples
and demographic data without identifying information. Inclu-
sion criteria for the neonates were full-term birth (38th to 42nd
gestational week), birth weight between 2,500 and 4,000 g, no
major birth defects, and singleton birth. We included mothers
without pregnancy complications, such as gestational or
chronic hypertensive disease, gestational or pre-gestational
diabetes mellitus, thyroid disease; who did not use hormonal
medications during pregnancy; and who had no known growth
hormone deficiency. Furthermore, the baby’s mother and father
were required to be of the same race, either black or white.
Delivery room nurses drew fifteen milliliters of blood into
two tubes containing sodium EDTA from the vein from each
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eligible baby’s umbilical cord. The samples were stored in a
refrigerator and processed usually within 12 h. After centri-
fugation for 15 min at 2,400 rpm at room temperature,
plasma, buffy coat, and red cells were aliquoted into cryovials
and stored at -70 C. The nurses collected information on
month and time (quadrant) of day of the birth, birth weight,
placental weight, mother/child’s race, and mother’s age,
parity (number of live births), and gravidity (number of
pregnancies) using a standardized form.
One hundred and thirteen male specimens, 38 white and
75 black, were collected and eligible for the study. Details
have been described previously [22].
Exposure assessment
25(OH)D and 1,25(OH)2D were measured at Heartland
Assays, Inc., (Ames, USA). 25(OH)D and other hydroxylated
metabolites were extracted from serum or plasma with ace-
tonitrile. Following extraction, the treated sample was then
assayed using an equilibrium radioimmunoassay (RIA) pro-
cedure. The RIA method is based on an antibody that is co-
specific for 25(OH)D2 and 25(OH)D3. The 25(OH)D assay
has a range of 2.5–100 ng/mL and intra- and inter-assay
coefficients of variation (CVs) of 8.0 and 10.0 %. Details of
the assay have been described previously [23]. The assay for
1,25(OH)2D involved a preliminary extraction and sub-
sequent purification of vitamin D metabolites from plasma
using C18OH cartridges. Following extraction, the treated
samples were then assayed using a competitive RIA proce-
dure. The RIA method is based on a polyclonal antibody that is
specific for both 1,25(OH)2D2 and 1,25(OH)2D3. The inter-
and intra-assay CVs for this assay are 12.6 and 9.8 %,
respectively. Details of the assay have been described previ-
ously [24]. The laboratory technicians were blinded to race
and hospital.
Testosterone, estradiol, and SHBG were previously
measured by competitive immunoassay (1010 Elecsys
autoanalyzer, Roche Diagnostics, Indianapolis, IN) and
androstanediol glucuronide by an enzyme immunoassay
(Diagnostic Systems Laboratory, Webster, TX) in the
laboratory of Dr. Nader Rifai, Children’s Hospital Boston
[22]. IGF-1, IGF-2, and IGF-binding protein (BP)-3 were
previously measured by ELISA (Diagnostics Systems
Laboratory, Webster, TX) in the laboratory of Dr. Michael
Pollak, Jewish General Hospital [22].
Statistical analysis
We calculated geometric mean plasma concentrations of
25(OH)D and 1,25(OH)2D in the cord blood of the black
and white male neonates because both analytes were not
normally distributed and tested for differences by race
using the t-test. We also present the geometric means
adjusted for season and mother’s parity estimated using
generalized linear models because season is an important
determinant of 25(OH)D concentration and mother’s parity
was correlated with 25(OH)D levels in black neonates. We
estimated the percentage of neonates with cord blood
25(OH)D concentrations \20 and \12 ng/mL, cutpoints
often used to define risk of suboptimal and risk of deficient
vitamin D levels [25].
We examined the correlation of IGF-I, IGF-II, IGFBP-3,
sex steroid hormones, and SHBG with concentration of
25(OH)D and 1,25(OH)2D by race using Spearman’s rank
correlation coefficient. All analyses were conducted using
SAS v. 9.1 (SAS Institute, Cary, NC).
Results
Table 1 shows the baseline characteristics of mothers and
newborns. At birth, mothers of white male neonates were
older than mothers of black male neonates, and they were
more often primipara. Mean birth weight was significantly
higher in white than in black neonates. The relative per-
centage of births by season differed between blacks and
whites, which is an artifact of the timing of the study in the
two hospitals.
25(OH)D and 1,25(OH)2 D levels were not statistically
significantly correlated with the age of the mother at birth
of the child or with the birth weight of the neonates
(Table 2). 25(OH)D concentration was statistically signif-
icantly inversely correlated with the mother’s parity in
Table 1 Maternal and birth characteristics by race, males, HUB
study 2004–2005
Blacks Whites p value
Number of cord blood
samples (N)
75 38
Mother’s age (year;
mean ± SD)
24.3 ± 6.1 28.7 ± 6.3 0.128a
Birth weight (g;
mean ± SD)
3,241 ± 346 3,470 ± 392 0.002a
Season (%)
Winter 28 10.5
Spring 53.3 68.4
Summer 2.7 10.5
Fall 16 10.5 0.049b
Mother’s parity (number of live births) (%)
0 29.3 63.2
1 36 21.1
2 17.3 10.5
3? 17.3 5.3 0.013b
a t-test
b Chi-square test
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black but not white male neonates. 25(OH)D concentra-
tions varied among the seasons of the year of birth in white
(lowest levels during winter, highest levels in fall) but not
in black neonates (Fig. 1). 1,25(OH)2D level varied by
season of the year of birth in both black and white neonates
similarly; the highest concentrations were seen in spring
and the lowest in winter.
Unadjusted mean 25(OH)D concentrations were signif-
icantly lower in black (11.44, 95 % CI 10.10–12.95 ng/mL)
than in white neonates (18.24, 15.32–21.72 ng/mL;
p \ 0.0001) (Table 3). The same was true for means
adjusted for mother’s parity and season of the year of birth.
Thirty-eighty percent of the newborns (32 % black and
50 % white) had 25(OH)D levels between 12 and\20 ng/mL,
and 39 % of the infants (52 % black and 13 % white) were
at risk of vitamin D deficiency [25(OH)D \12 ng/mL]. The
percentages of neonates with suboptimal vitamin D levels
[25(OH)D \20 ng/mL] were much higher in black male
neonates than in white male neonates (84 vs. 63 %). Mean
1,25(OH)2D concentrations did not differ significantly
between black (31.98, 95 % CI 29.77–34.34 pg/mL) and
white (31.94, 28.85–35.36; p = 0.99; Table 3) neonates.
Concentrations of 25(OH)D and 1,25(OH)2D were statis-
tically significantly correlated in white (Spearman’s cor-
relation coefficient: 0.61, p \ 0.0001) and black (0.59,
p \ 0.0001) neonates. We examined 1,25(OH)2D levels
after stratifying into neonates with levels below and equal
or above 20 ng/mL but did not observe statistically sig-
nificant differences between black and white neonates
when looking at low levels of 25(OH)D (black 30.00 pg/mL
[95 % CI 28.01–32.14]; white 29.87 pg/mL [26.66–33.47];
p value 0.95) or at 25(OH)D levels above 20 ng/mL (black
44.33 pg/mL [95 % CI 37.07–53.00]; white 36.40 pg/mL
[30.66–43.22]; p value 0.13).
After adjusting for season of the year of birth and
mother’s parity, which was correlated with 25(OH)D levels
in black neonates, cord blood levels of 25(OH)D and
1,25(OH)2D were not correlated with cord blood levels of
sex steroid hormones and growth factors (IGFs) (Table 4).
Discussion
In the present study, we observed that, in a group of 38
white and 75 black male full-term neonates born in
Maryland, United States, the percentage with suboptimal
vitamin D levels [25(OH)D \20 ng/mL] was much higher
in black (84 %) than in white (63 %) male neonates.
25(OH)D concentration varied among the seasons in white
but not in black neonates. 1,25(OH)2D cord blood level did
Table 2 Partial Spearman’s correlation coefficients between mater-
nal and birth characteristics and 25-hydroxyvitamin D (25(OH)D) and
1,25-dihydroxyvitamin D (1,25(OH)2D) concentrations in venous
umbilical cord blood of black and white neonates, males, HUB study
2004–2005
Blacks Whites
25(OH)D 1,25(OH)2D 25(OH)D 1,25(OH)2D
Birth weight
Spearman r -0.063 0.148 -0.081 0.021
p value 0.59 0.21 0.63 0.9
Placental weight
Spearman r -0.025 0.148 -0.016 0.021
p value 0.84 0.21 0.92 0.9
Mother’s parity (number of live births)
Spearman r -0.283 -0.146 -0.071 0.205
p value 0.01 0.21 0.67 0.22
Mother’s age
Spearman r 0.115 0.146 0.15 -0.069
p value 0.33 0.21 0.38 0.69
Fig. 1 Geometric mean
25-hydroxyvitamin
D (25(OH)D) and
1,25-dihydroxyvitamin D
(1,25(OH)2D) concentrations
(and 95 % CI) in venous
umbilical cord blood of black
and white neonates, by season
of the year of birth, males HUB
study 2004–2005
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not differ between races, but was correlated with 25(OH)D
levels in both races. 25(OH)D and 1, 25(OH)2D levels were
not correlated with IGFs, sex steroid hormones, or SHBG.
Because of the small sample size, we cannot rule out
chance as an explanation for our findings.
25(OH)D
Compared to the unadjusted mean values of 25(OH)D of
20.4 ng/mL in white and 13.4 ng/mL in black male
neonates in our study, the vitamin D concentrations in the
few other US studies ranged from 14.9 to 27 ng/mL in
white and 9.5–15.7 ng/mL in black neonates [12, 16, 17, 26].
The lowest levels were observed in cord blood samples
taken in winter/early spring [12, 16, 26]. In comparison
with the 84 % of the black and 63 % of the white male
neonates with suboptimal levels of 25(OH)D\20 ng/mL in
our study, in the study by Merewood et al. in Boston [12],
67.4 % of black and 37.5 % of non-Hispanic white neo-
nates had 25(OH)D levels of \20 ng/mL. The percentage
of neonates born in summer was much lower in our study
than in their study (2.7 % in blacks and 10.5 % in whites
compared to 25.8 % in the study by Merewood [12]). The
seasonal changes in 25(OH)D concentrations are well
recognized [12, 18, 27]. In the present study, 25(OH)D
concentration varied among the seasons in white but not in
black male neonates. Our results are in line with the find-
ings of a study by Basile et al. [28], in which vitamin D
status was measured in neonates (including 20 % preterm
neonates) at latitude 32720 (southeastern United States).
The mean 25(OH)D level at birth in November–March
compared to April–October was 11.3 ng/mL lower in white
infants (from 29.0 to 17.7 ng/mL) and 3 ng/mL lower in
black infants (from 13.1 to 10.1 ng/mL). Seasonality, while
significant in both groups, had a greater impact on the
vitamin D status of white newborns to recover to adequate
levels, as in our study.
The vitamin D status of newborns is also closely related
to maternal vitamin D status [29]. A secondary analysis of
928 pregnant and 5,173 non-pregnant women aged
13-44 years from the National Health and Nutrition
Examination Survey 2001–2006 [30] found that 13 % of
white and 80 % of black pregnant women and 26 % of
white and 86 % of black non-pregnant women were at risk
of suboptimal vitamin D levels (25(OH)D \50 nmol/
L = \20 ng/mL). In the present study, 25(OH)D concen-
tration was inversely correlated with the mother’s parity in
black but not in white neonates. We hypothesize that the
increased need for vitamin D during pregnancy might
Table 3 Geometric mean (and
95 % CI) 25-hydroxyvitamin D
(25(OH)D) and
1,25-dihydroxyvitamin D
(1,25(OH)2D) concentrations in
venous umbilical cord blood of
white and black neonates,
males, HUB study 2004–2005
a Adjusted for season of the
year of birth and mother’s parity
Blacks Whites p value
geometric
mean
95 % CI geometric
mean
95 % CI
Unadjusted
25(OH)D (ng/mL) 11.44 10.10–12.95 18.24 15.32–21.72 \0.0001
1,25(OH)2D (pg/mL) 31.98 29.77–34.34 31.94 28.85–35.36 0.986
Adjusteda
25(OH)D (ng/mL) 11.71 10.36–13.24 17.41 14.63–20.73 0.0003
1,25(OH)2D (pg/mL) 32.22 29.99–34.63 31.45 28.35–34.89 0.712
Spearman’s correlation between
25(OH)D and 1,25(OH)2D
(p value)
0.592 (p \ .0001) 0.61 (p \ .0001)
Table 4 Partial Spearman’s correlation coefficientsa between
25-hydroxyvitamin D (25(OH)D) and 1,25-dihydroxyvitamin D
(1,25(OH)2D) concentrations and sex steroid hormones and IGF axis
concentrations in venous umbilical cord blood of black and white
neonates, males, HUB study 2004–2005
Blacks Whites
25(OH)D 1,25(OH)2D 25(OH)D 1,25(OH)2D
IGF-1
Spearman r -0.002 -0.009 -0.005 -0.057
p value 0.99 0.942 0.979 0.744
IGF-2
Spearman r 0.134 0.083 0.091 0.099
p value 0.26 0.488 0.604 0.57
IGF-binding protein-3
Spearman r -0.048 0.104 0.165 0.015
p value 0.69 0.387 0.345 0.934
Testosterone
Spearman r 0.167 0.11 0.103 -0.056
p value 0.16 0.358 0.555 0.748
Estradiol
Spearman r 0.052 -0.122 0.152 0.038
p value 0.666 0.309 0.384 0.83
Sex hormone-binding globulin
Spearman r -0.051 0.019 -0.038 -0.057
p value 0.672 0.873 0.827 0.746
a Adjusted for season of the year of birth and mother’s parity
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deteriorate the suboptimal status of the mothers further, and
multiparity may lead to an inability of the vitamin D status
to recover to adequate levels between pregnancies. Overall,
the findings among the studies addressing this question are
not consistent [31–35].
1,25(OH)2D
The assessment of serum 25(OH)D concentrations is gen-
erally considered to be the best approach for determining
human vitamin D status [36]. 25(OH)D is biologically inert
and must be converted to its biologically active form,
1,25(OH)2D. The production of 1,25(OH)2D is under
stringent control [37, 38]. Serum 1,25(OH) levels are often
normal or even elevated in vitamin D deficiency [18]. A
few epidemiological studies reported associations between
blood levels of 1,25(OH)2D and chronic diseases [27, 39–41].
In the present study, circulating levels of 1,25(OH)2D and
25(OH)D cord blood levels were highly correlated in both
races. No differences of 1,25(OH)2D cord blood levels
between black and white male neonates were observed.
Only a few other studies examined differences in circu-
lating levels of 1,25(OH)2D between different racial groups
and, with one exception [42], no differences were observed
[15, 43].
IGFs and 25(OH)D and 1,25(OH)2D concentrations
Insulin-like growth factors (IGFs) are multifunctional pep-
tides that regulate cell proliferation, differentiation, and
apoptosis [44]. IGF-I stimulates renal and placental
1,25(OH)2D production [19]. In a previous analysis in the
same sample of neonates, we observed lower cord blood IGF-
1 and IGF-2 levels in black compared with white male neo-
nates [22]. In the present study, we found no associations
between IGF growth factors and cord levels of 1,25(OH)2D or
25(OH)D. So far, one study reported a positive correlation
between IGF-I and 1,25(OH)2D concentrations in serum of
normotensive mothers but no significant correlation in the
cord blood of their neonates. However, a statistically signifi-
cant correlation was observed in cord blood of neonates of
mothers with preeclampsia [20]. IGF-II is another growth
factor, which is more important during fetal development than
IGF-I [44], but whose association with vitamin D levels in
cord blood has, to the best of our knowledge, not been ana-
lyzed in previous studies.
Sex steroid hormones and 25(OH)D and 1,25(OH)2D
concentrations
In the already mentioned previous analysis in the same
sample of neonates, we found a higher cord blood testos-
terone to SHBG ratio in black than in white male neonates
after taking into account maternal and birth factors [22]. In
the present study, no associations were observed between
cord blood concentrations of 25(OH)D, and 1,25(OH)2D
and testosterone, estradiol, and SHBG. A Finnish study
observed no association between circulating 25(OH)D and
testosterone and estradiol as well as other sex steroid
hormones (progesterone, 17-hydroxyprogesterone, and
androstenedione) among pregnant women [35]. An inter-
vention in young non-pregnant women showed that per
supplemented increase of 10 nmol/L of 25(OH)D, estradiol
and progesterone decreased significantly by a factor of 3
and 10 %, respectively [45].
Strengths and Limitations
Cord blood from black and white male neonates was
sampled according to a standardized protocol during the
same time period between 2004 and 2005 at two hospitals
in the Baltimore–Washington, DC, area. This reduces one
source of vitamin D variation between blacks and whites as
the mothers of the neonates lived at the same latitude.
Given our inclusion and exclusion criteria, we sampled a
relatively homogeneous group of neonates, excluding
extremely large or small neonates, neonates born to
mothers with pregnancy complications, and neonates with
major birth defects. This allowed for elucidating racial
differences in vitamin D cord blood levels and their asso-
ciation with IGF-I and sex steroid levels in healthy neo-
nates. Many previous studies have, in contrast, been
conducted among neonates small-for-gestational-age or
born from mothers with pregnancy complications.
Because this study was designed to collect anonymous
cord blood specimens as discarded human tissue, we did
not collect information from the mothers about their diet or
outdoor behavior during the pregnancy. We also did not
collect blood specimens from the mothers, so we were not
able to correlate mother’s with baby’s circulating vitamin
D concentrations or adjust for the mother’s behaviors
affecting vitamin D status during pregnancy. Lastly, we
measured vitamin D in our samples, which were collected
5 years ago and have been frozen at -70 C. However,
25(OH)D is extremely stable in samples frozen at -20 C
for at least 2 years [46–48]. Furthermore, only slight
deterioration of serum 25(OD)D was observed in a study
by Bodnar et al. [49] after C40 years of storage.
Samples from black neonates were collected from two
hospitals, whereas samples from white neonates were col-
lected only in one [22]. However, vitamin D levels between
black neonates from hospital 1 and hospital 2 were com-
parable as was birth weight of the neonates, and mothers
did not differ with respect to parity and age at birth (data
not shown), such that they were analyzed together.
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Conclusions
Risk of suboptimal vitamin D levels (25(OH)D\20 ng/mL)
may be prevalent in US male newborns based on a sample
from the Mid-Atlantic region, although our samples are
small and not representative of the population. Black male
neonates were substantially more likely to have low cord
blood vitamin D levels. Their risk increased with mother’s
parity and also in white male neonates if born in the winter.
Vitamin D levels were not correlated with levels of sex ste-
roid hormones, SHBG, or IGFs. The observed vitamin D
disparity between black and white male neonates warrants
further evaluation in the etiology of the disparity in chronic
disease risk in adulthood.
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